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Abstract
Tissue engineering provides unique opportunities for regenerating diseased or damaged tissues using cells obtained from
tissue biopsies. Tissue engineered grafts can also be used as high fidelity models to probe cellular and molecular
interactions underlying developmental processes. In this study, we co-cultured human umbilical vein endothelial cells
(HUVECs) and human mesenchymal stem cells (MSCs) under various environmental conditions to elicit synergistic
interactions leading to the colocalized development of capillary-like and bone-like tissues. Cells were encapsulated at the
1:1 ratio in fibrin gel to screen compositions of endothelial growth medium (EGM) and osteogenic medium (OM). It was
determined that, to form both tissues, co-cultures should first be supplied with EGM followed by a 1:1 cocktail of the two
media types containing bone morphogenetic protein-2. Subsequent studies of HUVECs and MSCs cultured in decellularized,
trabecular bone scaffolds for 6 weeks assessed the effects on tissue construct of both temporal variations in growth-factor
availability and addition of fresh cells. The resulting grafts were implanted subcutaneously into nude mice to determine the
phenotype stability and functionality of engineered vessels. Two important findings resulted from these studies: (i) vascular
development needs to be induced prior to osteogenesis, and (ii) the addition of additional hMSCs at the osteogenic
induction stage improves both tissue outcomes, as shown by increased bone volume fraction, osteoid deposition, close
proximity of bone proteins to vascular networks, and anastomosis of vascular networks with the host vasculature.
Interestingly, these observations compare well with what has been described for native development. We propose that our
cultivation system can mimic various aspects of endothelial cell – osteogenic precursor interactions in vivo, and could find
utility as a model for studies of heterotypic cellular interactions that couple blood vessel formation with osteogenesis.
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Introduction
In native bone, synergistic interactions between osteoblasts/
osteogenic precursors and endothelial cells enable coordinated
development of vasculature and mineralized tissue. In the process
of intramembranous ossification during craniofacial bone growth,
this cell coupling results in close spatial relationships between the
two tissues in newly forming bone, with the vascular network
serving as a ‘template’ for bone mineral deposition [1]. A synergy
between the two cell populations has also been observed during
endochondral ossification. A murine model was used to demon-
strate that when the HIF-1a protein was constitutively activated in
osteoblasts by conditional deletion of the Vhl gene, the result was
higher vascularity in long bones with complementary increases in
bone volumes [2]. In a recent study, it was shown that osteoblast
precursors occupy pericytic locations as they invade the cartilage
template along with blood vessels to form new trabecular bone
during ossification of long bones [3]. Still, many of the
mechanisms guiding interactions between endothelial cells and
osteogenic precursors remain largely unknown due to the
complexity of the in vivo environment.
The need to vascularize tissue engineered bone grafts, during
culture and following implantation, has led to studies between
endothelial cells and osteoblasts/osteo-progenitors [4,5,6,7]. Inter-
estingly, despite the preponderance of evidence linking vascular
development and osteogenesis in vivo, it has been decidedly difficult
to simultaneously form capillary-like networks and mineralized
deposits in vitro, within a single culture environment. Whereas
beneficial effects of osteogenic precursors on vascular network
formation have been demonstrated [7,8], adequate formation of
bone-like tissue within the same constructs has not been achieved.
The effect of endothelial population on osteogenesis remains
conflicting: some studies have indicated a positive effect of
endothelial cells on mineral deposition [6,9,10,11,12], while other
studies have described molecular pathways via which endothelial
cells inhibited osteogenesis [13,14].
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Recently, one group circumvented the difficulty of inducing
adequate vascular development and osteogenic differentiation by
seeding mesenchymal stem cells (MSCs) into polymer scaffolds and
inducing osteogenesis prior to seeding MSCs and human umbilical
vein endothelial cells (HUVECs) into a gel substrate [15]. When
these constructs were implanted subcutaneously into the dorsum of
nude mice, developed vascular networks anastomosed to the host
vasculature, while after eight weeks of in vivo cultivation evidence of
mineral deposition was revealed. Several other groups have shown
that implanting biomaterial constructs with a mixture of
mesenchymal and vascular or hematopoietic progenitor cells
enabled the development of vascularized tissues in vivo
[12,16,17,18]. However, realistic in vitro cultivation models are
required to elucidate the mechanistic interactions of both cell
populations during the formation of vascularized bone.
In this study, we hypothesize that the sequential application of
growth factors, to firstly induce the formation of stable vasculature
and subsequently initiate osteogenic differentiation, could provide
a biologically-inspired in vitro model of bone vascularization.
HUVECs and human MSCs were cultured in decellularized
trabecular bone constructs using fibrin as a cell carrier to provide
an environment conducive to the formation of capillary-like
networks. Coordinated development of the two tissue compart-
ments was evaluated over a two-stage procedure (6 weeks in vitro
culture followed by a 2 week sub-cutaneous implantation), to
establish an alternative model for engineering bone-like constructs
containing vascular networks (Fig. 1).
Materials and Methods
Materials
Fetal bovine serum (FBS), Dulbecco’s Modified Eagle Medium
(DMEM), Penicillin–Streptomycin (Pen–Strep), HEPES and
trypsin/EDTA were obtained from Invitrogen (Carlsbad, CA).
Ascorbic acid-2-phosphate, dexamethasone, sodium-b-glycero-
phosphate, Triton X-100, fibrinogen and thrombin were obtained
from Sigma-Aldrich (St. Louis, MO). Basic fibroblast growth
factor (bFGF) and bone morphogenetic protein 2 (BMP2) were
obtained from Peprotech (Rocky Hill, NJ). Endothelial Growth
Medium-2 (EGM) was obtained from Lonza (Walkersville, MD).
Phosphate buffered saline (PBS) and proteinase K were obtained
from Fisher Scientific (Pittsburgh, PA). All other substances were
of analytical or pharmaceutical grade and obtained from Sigma-
Aldrich.
Human Mesenchymal Stem Cells (MSCs)
Bone marrow-derived human mesenchymal stem cells (MSCs)
were isolated from the mononuclear fraction of a bone marrow
aspirate obtained from a commercial source (Cambrex, CA) based
on their attachment to tissue culture plastics [19], expanded in
high glucose DMEM supplemented with 10% FBS, 1% Pen–Strep
and 1 ng/mL basic fibroblast growth factor (bFGF) to the 3rd
passage. These cells have been characterized for their ability to
differentiate into osteogenic, chondrogenic, and adipogenic
phenotypes in vitro and for their ability to give rise to new bone
formation in vitro and in vivo [19,20,21]. Three independent series
of experiments were performed, each with triplicates of samples
for each experimental group, data point and analytical method.
Human umbilical vein endothelial cells (HUVECs)
Fresh umbilical veins were obtained from the neonatal unit at
Columbia University following an approved IRB protocol
(IRBAAAC4839). To isolate HUVECs, the vein was flushed with
HEPES buffer to remove residual blood and treated with trypsin
for 15 minutes to remove the endothelial cells. Cells were flushed
from the vein with HEPES and collected in centrifuge tubes. The
suspension was centrifuged at 300 g for 5 minutes and the
supernatant was discarded. Cells were resuspended in EGM and
cultured in tissue culture flasks. Non-adherent cells were washed
out after 1 day. When the HUVECs grew to confluence, they were
trypsinized, counted and cryopreserved.
Medium screening studies
In this study, HUVECs were expanded in EGM to the 4th
passage. HUVECs used in preliminary screening studies were
suspended in serum-free medium at 16106 cells/mL and then
incubated with 10 ml/mL of Vybrant DiI (Molecular Probes) for
Figure 1. Schematic of experimental approaches. Groups 1 & 2 are ‘controls’ where constructs were provided osteogenic supplements (OM) or
endothelial factors (EGM) for 6 weeks. In Groups 3 & 4, vascular differentiation was induced for 2 weeks before adding osteogenic factors in a cocktail
medium (EGM+OM at 1:1 ratio). No additional cells were added at this point in Group 3 (EGM|cocktail), while osteo-induced MSCs were seeded into
the pore spaces in Group 4 (EGM|cocktail+MSCs). These were compared with cultures in Group 5 where only MSCs were added initially and
cultured in OM for 4 weeks. A co-culture of HUVECs and MSCs were then added and constructs cultured in cocktail medium (OM|cocktail) for
remaining 2 weeks. Constructs of all groups were implaneted sub-cutaneously in nude mice for additional 2 weeks.
doi:10.1371/journal.pone.0028352.g001
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30 minutes at 37uC. The cells were washed of excess dye three
times prior to mixing with hMSCs in a 1:1 ratio, and
encapsulation in fibrin hydrogel in the wells of a 96-well plate
and cultured for 4 weeks in vitro. A 1:1 ratio was chosen in pilot
studies (data not shown) as it provided robust and stable vascular
networks while enabling bone formation. The hydrogels were
divided into five groups depending on the various growth medium
provided the constructs. These included osteogenic medium (OM)
containing low glucose DMEM, 10% FBS, 1% Pen–Strep
supplemented with osteogenic factors: 100 nM dexamethasone,
10 mM sodium-b-glycerophosphate, and 50 mg/mL ascorbic acid-
2-phosphate. The other groups were provided EGM or a cocktail
of OM and EGM in a 1:1 ratio. The temporal sequence was
investigated by providing the cells EGM only for 2 weeks followed
by cocktail for the subsequent two weeks or cocktail medium
supplemented with 10 ng/ml of BMP-2. The development of
vascular structures was imaged with a Zeiss 510 confocal
microscope using an image stack 200 mm thick with 10 mm
spacing between slices.
Decellularized bone scaffolds
Bone plugs (4 mm diameter62 mm high) were prepared as in
our previous studies [22]. Briefly, trabecular bone was cored from
the subchondral region of carpometacarpal joints of 2-week to 4-
month old bovine calves, washed with high velocity stream of
water to remove the marrow from the pore spaces, followed by
sequential washes in PBS, hypotonic buffer, detergent and
enzymatic solution to remove any remaining cellular material.
At the end of the process, decellularized bone plugs were rinsed
repeatedly in PBS, freeze-dried and cut into scaffolds for cell
cultivation. The dry weight and exact length of each plug was
measured and used to calculate the scaffold density and porosity.
Scaffolds were sterilized in 70% ethanol for one day and incubated
in culture medium overnight prior to cell seeding.
Cell encapsulation and seeding
To induce bone formation, 20 ml suspension of MSCs at a
density of 106106 cells/mL was seeded into blot-dried scaffolds,
divided into five groups, and incubated overnight to allow cell
attachment as shown in Fig. 1. At day 1, the solutions of
fibrinogen (5 mg/mL) and thrombin (10 Units/mL) were
prepared. In Groups 1–4, HUVECs and MSCs, intended to form
stable vasculature network, were encapsulated in fibrin at a 2:1
ratio and a density of 306106 cells/mL. Thrombin was added to
crosslink the gel, giving a final fibrin concentration of 4 mg/mL.
Before crosslinking occurred, 20 ml of cell/gel suspension was
pipetted into blot-dried scaffolds to allow uniform cell seeding
throughout the scaffolds. Before the gels became fully cross-linked,
they were aspirated under a light vacuum so that the fibrin gel
coated the walls of the scaffolds, but did not fill the pore spaces. In
Group 5, this same step was performed on MSC-seeded scaffolds
after 4 weeks of osteogenic culture.
In vitro culture
Five experimental groups were established to study vascularized
bone constructs, including three main groups and two controls
(Fig. 1). Group 1 (control for osteogenic conditions) utilized
osteogenic medium (OM) throughout the culture, containing low
glucose DMEM, 10% FBS, 1% Pen–Strep supplemented with
osteogenic factors: 100 nM dexamethasone, 10 mM sodium-b-
glycerophosphate, and 50 mg/mL ascorbic acid-2-phosphate,
supplemented with BMP-2 (at 10 ng/mL) for 6 weeks. Group 2
(control for vasculogenic conditions) utilized endothelial growth
medium (EGM) throughout the culture. Group 3 utilized EGM
for 2 weeks and then a cocktail medium composed by EGM and
OM at 1:1 ratio (EGM|cocktail) for 4 weeks. Group 4 was
designed exactly as Group 3 except that osteo-induced MSCs were
added into scaffold pore spaces at the 2-week time point
(EGM|cocktail+MSC). In Group 5, MSCs only were seeded
into the scaffolds and cultured in osteogenic medium for 4 weeks,
at which point HUVECs and MSCs in fibrin were added to the
constructs and cultured in cocktail medium for an additional 2
weeks (OM|cocktail).
In vivo implantation
After 6 weeks of in vitro culture, constructs of all groups were
evaluated for 2 weeks in a subcutaneous implantation nude
mouse model in vivo. NOD SCID mice (NOD.CB17-Prkdcscid/
NCrHsd, Harlan) were anaesthetized by a subcutaneous injection
of ketamine (80–100 mg/kg) and xylazine (5–10 mg/kg). Anal-
gesia was provided with buprenorphine (0.05–0.1 mg/kg).
Constructs were implanted into separate subcutaneous dorsal
pockets (one construct per pocket, two pockets per animal)
according to an approved Columbia University Institutional
Animal Care and Use Committee (IACUC) protocol. Implants
were retrieved after 2 weeks for analysis of blood vessel
anastomosis and bone growth.
DNA assay
Constructs were washed in PBS, cut in half, placed into micro-
centrifuge tubes and incubated overnight at 56uC in 1 mL of
digestion buffer (10 mM Tris, 1 mM EDTA and 0.1% Triton X-
100) containing 0.1 mg/mL proteinase K. The supernatants were
collected and diluted 10 times to bring into the linear range of the
Picogreen assay. A standard curve was prepared from a solution of
bacteriophage l DNA obtained from Molecular Probes. Picogreen
dye (Molecular Probes, OR) was added to the samples in 96-well
plates (100 mL dye into each 100 mL sample) and read in a
fluorescent plate reader (excitation 485 nm, emission 528 nm).
Live-Dead assay
Constructs were cut in half, washed in PBS, incubated with
calcein AM (indicating live cells) and ethidium homodimer-1
(indicating dead cells) according to manufacturer’s protocol
(LIVE/DEAD (R) Viability/Cytotoxicity Kit, Molecular Probes)
and imaged on a confocal microscope. Optical slices were taken
from the surface at 10 mm intervals, up to the depth of 160 mm
and presented as a vertical projection.
Immunohistochemistry
Constructs were washed in PBS and fixed in 10% formalin for 1
day. Samples were then decalcified for 2 days with Immunocal
solution, dehydrated in graded ethanol washes, embedded in
paraffin, sectioned to 5 mm and mounted on glass slides. Sections
were deparaffinized with Citrisolv, rehydrated with a graded series
of ethanol washes, blocked with normal serum, and stained with
primary antibodies followed by the secondary antibody and
development with a biotin/avidin system. Immunohistochemistry
was performed for anti-human collagen I (Abcam ab6308), bone
sialoprotein II (BSP) (Chemicon AB1854), CD31 (Millipore 04-
1074) and von Willebrand factor (vWF) (Sigma-Aldrich F3520).
Counterstaining was performed with hematoxylin. The serum,
secondary antibody and developing reagents were obtained from
Vector Laboratories and included in the Vector Elite ABC kit
(universal) (PK6200) and DAB/Ni Substrate kit (SK-4100).
Negative controls were performed by omitting the primary
antibody incubation step.
In Vitro Model of Vascularized Bone
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Micro Computerized Tomography (mCT)
mCT was performed on all five cell-seeded groups after 6 weeks
of in vitro culture. As a control, unseeded scaffolds were remained
in OM throughout culturing period and analyzed at this time
point. A modification of a previously developed protocol was used
[23]. The samples were aligned along their axial direction and
stabilized in a 2 mL centrifuge tube that was clamped within the
specimen holder of a vivaCT 40 system (SCANCO Medical AG,
Basserdorf, Switzerland). The 2 mm length of the scaffold was
scanned at a 21 mm isotropic voxel size. The total bone volume
(BV), accounting for the sum of the bone matrix in the scaffold and
the new mineralized bone, was obtained from the application of a
global thresholding technique so that only the mineralized tissue is
detected. The bone volume fraction (BV/TV) was calculated as
the ratio of the BV and the total volume (TV) of the sample.
Spatial resolution of this full voxel model was considered sufficient
for evaluating the micro-architecture of the samples.
Evaluation of in vivo anastomosis and new bone
formation
After 2 weeks of subcutaneous implantation in NOD SCID
mice, samples were harvested, washed in PBS and macroscopic
photographs were taken with the stereomicroscope. Samples were
cut in half, and used for soft and hard tissue histology. Anastomosis
of in vitro developed capillary networks with host vasculature was
evaluated by immunolocalization of human CD31 (Millipore 04-
1074) as described above. Counterstaining with hematoxylin was
performed to detect mouse red blood cells within human capillary
lumen. New bone formation was evaluated on undecalcified
sections processed according to hard tissue histology methods:
constructs were fixed in 10% formalin for 1 day and dehydrated
with sequential washes in 70% ethanol (2 days), 100% ethanol (2
days with twice daily solution changes), and toluene (2 days with
once daily solution change). Constructs were then washed in
activated methyl methacrylate (MMA) with daily changes of MMA
solution for four days at 4uC, and then placed at 32uC until the
MMA cured. Plastic-embedded sections were sectioned to 8 mm
on a Leica hard tissue microtome. Staining for the new osteoid
formation was done using the traditional Goldner’s Masson
trichrome stain.
Statistics
Statistical analysis was performed using the GraphPad Prism
4.0c software. A one-way analysis of variance (ANOVA) with
Tukey’s multiple comparison post-hoc test was used to verify
statistically significant differences among groups. p,0.05 were
considered statistically significant. Data is presented as mean6SD.
Results
Formation of vascular networks in fibrin hydrogels
We confirmed that capillary networks formed from HUVECs
are stable in vitro only in the presence of MSCs (Fig. S1). Robust
networks were observed in confocal microscopy within two weeks
of culture in constructs cultured in endothelial growth media (Fig.
S2 – EGM group) and remained stable throughout the 6 weeks of
cultivation. When OM was used at the beginning of the culture
period (Fig. S2 – OM group), the cells did not form networks.
Instead, significant amounts of ‘debris’ from the diI-stained
HUVECs were observed by confocal (and used as a pseudo
parameter for evaluating HUVEC viability). Cells in the cocktail
medium (EGM+OM 1:1 ratio) formed vascular networks, as
evidenced via confocal imaging of the pre-stained HUVECs,
however high amount of cell debris was observed (Fig. S2 –
cocktail group).
Sequential induction was investigated in Group 3 and Group 4
constructs, using EGM first, since HUVECs did not survive well if
OM was used first. In both groups, vascular networks that formed
within the first two weeks were maintained for the duration
of culture. However, supplementation of cocktail medium
(EGM+OM 1:1 ratio) with BMP-2 (10 ng/mL) significantly
decreased the amount of cell debris, suggesting that BMP-2 may
help maintain the viability of the endothelial cell population (Fig.
S2 – EGM|cocktail+BMP group).
The amount and pattern of mineral deposition also differed
significantly when sequential induction was utilized (Groups 3 and
4) as compared to the osteogenic conditions applied throughout
culture (Group 1). Notably, the new mineral deposition was
observed mostly in the close spatial proximity to vascular
networks, particularly in the EGM|cocktail+BMP2 group.
From these studies, it was determined that sequential induction
was needed to facilitate the development of both structures within
single constructs for bone tissue engineering applications.
Formation of bone and capillary networks in scaffolds
cultured in vitro
Based on the screening studies performed on fibrin gel, we chose
to supplement all osteogenic medium with BMP-2 for its role in
maintaining the viability of the endothelial population. HUVECs
and hMSCs were seeded uniformly throughout the decellularized
bone scaffold and located predominantly on the wall surfaces (Fig.
S3). The DNA content of constructs revealed that OM enhanced
cell proliferation considerably more than EGM (p,0.05). This
was clearly a specific cellular response to factors in the OM
medium since EGM|cocktail also had more cells than EGM
only. Not surprisingly, Group 4 (EGM|cocktail+MSC) and
Group 5 (OM|cocktail) had the most cells (Fig. 2), given that
more cells were added to these constructs. Confocal microscopy
demonstrated cell viability in all groups (Live/Dead assay) and
robust capillary networks, in Group 3 and Group 4 (calcein assay)
(Fig. 2).
The two control groups, OM (Group 1, osteo-induction) and
EGM (Group 2, vascular induction) were compared to Groups 3,
4 and 5 where vascular supplements were applied in sequence with
osteogenic supplements. Anti-human CD31 and vWF staining
demonstrated formation of vascular structures in all groups except
for the OM (Group 1). Vascular structures were clearly most
developed in EGM|cocktail (Group 3) and EGM|cock-
tail+MSC (Group 4). While there were CD31 and vWF positive
cells in the OM|cocktail groups, the vascular networks did not
show signs of maturity as evidenced by the sizes of lumens in the
structures (Fig. 3).
The OM group stained most intensely for collagen I and bone
sialoprotein II (BSP), which are indicative of osteogenic differen-
tiation, with incorporation of both collagen and BSP into the new
tissue matrix. In contrast, the osteogenic markers in the EGM
group were confined to individual cells. In the EGM|cock-
tail+MSC group, high expression of BSP was observed in spatial
proximity to lumenal structures (Fig. 3). BV/TV of tissue
constructs, determined by mCT, demonstrated a concordant
trend: constructs that were cultured for 6 weeks in osteogenic
medium showed the highest BV/TV, while those cultured in
endothelial growth medium, show the lowest BV/TV that was
close to that observed for unseeded scaffolds. In all other groups,
the BV/TV was comparable to that in the OM group, being
highest for the EGM|cocktail+MSC group (Fig. 4).
In Vitro Model of Vascularized Bone
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Figure 2. DNA contents of constructs after 6 weeks of in vitro culture. Upper: Horizontal line indicates day 1 values. n = 3; * indicate p,0.05
in comparison to day 1 values. # indicate p,0.05 among groups. Lower: Live/dead imaging of constructs after in vivo culture. Scale bar = 200 mm.
doi:10.1371/journal.pone.0028352.g002
Figure 3. Immunohistological analysis of constructs cultured in vitro. Engineered bone grafts were evaluated for the expression of vascular
and osteogenic proteins. CD31 (black arrows) and vWF (indicated by *) expression was observed in constructs from all groups. Vascular structures
were most developed in EGM|cocktail and EGM|cocktail+MSC groups. Collagen I and BSP were readily apparent in the OM group. Expression
was observed in individual cells in EGM group, but not distributed through matrix. Both collagen I and BSP were observed in all other groups. In
EGM|cocktail+MSC group, BSP appeared in close proximity to the vascular structures. Scale bar = 20 mm.
doi:10.1371/journal.pone.0028352.g003
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Properties of capillary networks in vivo
Macroscopic photographs taken with the stereomicroscope
indicated in-growth of large, well-developed blood vessels into
each of the constructs (Fig. 5). In some groups, blood perfusion
through microvascular network structures was also observed. Only
a few capillaries were seen in the OM group, as compared to a
higher vascular density in the EGM group. Groups 3 and 4, where
vasculogenesis was induced prior to osteogenic differentiation,
showed the development of the most robust capillary networks.
Decalcified constructs were stained with anti-human CD31 to
confirm that the vascular networks present prior to implantation
remained viable and functional in vivo. Positively stained structures
were found with cells inside, in all groups where vasculogenesis
was induced prior to osteogenesis (Groups 3 and 4) suggesting that
the perfused microvasculature might be of human origin (Fig. 5
and Fig. S4). Although there were positively stained cells in the
OM|cocktail group, these vessels were not well developed and
there was no evidence of perfusion. Non-decalcified grafts
harvested from in vivo studies were stained with Goldner’s Masson
Trichrome to visualize osteoids, which were observed to a higher
extent in the OM and EGM|cocktail+MSC groups. Clearly,
the least osteoid formation was observed in the EGM group.
Proposed model of the development of vascularized
bone in vitro
In initial hydrogel studies, we found that providing osteogenic
medium to co-cultures of HUVECs and hMSCs was detrimental
to vascular formation. As a result, subsequent studies induced
robust vascular development through the application of EGM for
two weeks. Early studies demonstrated that the capillary-like
structures were formed by HUVECs within a couple days and
were only stable in the presence of hMSCs. This suggests that the
hMSCs may be playing a pericyte-like role in this system
(Figure 6). One prevailing view in the literature is that the
process of perivascular cell migration and recruitment is mediated
by PDGFR signaling [24,25,26]. Sequential addition of osteogenic
factors to the EGM, and potential BMP expression by EC’s [27]
facilitated de novo bone formation by undifferentiated hMSCs over
a period of several weeks. The bone formation was augmented
when osteo-induced MSCs were added to the bone scaffolds at the
same time as the osteogenic supplements. Moreover, several
studies have shown that BMP stimulate VEGF expression in
osteoblasts, and VEGF up-regulate BMP-2 mRNA and protein
expression in microvascular endothelial cells [27,28].
Discussion
The major goal of this study was to test the hypothesis that the
sequential application of growth factors, to first induce the
formation of stable vasculature and then initiate osteogenic
differentiation, could provide a biologically-inspired in vitro model
of bone vascularization. To this end, we systematically studied
cultivation conditions that give rise to both functional vascular
structures and robust osteogenesis using HUVEC-MSC co-
cultures in conjunction with previously developed tissue engineer-
ing and bioreactor methods [19,20,29]. We propose that the
system used in this study might provide a high-fidelity tissue
engineering model of vascularized bone for mechanistic studies of
heterotypic cell-cell interactions between endothelial cells and
osteo-progenitors. In fact, a recent study showing that vascular
endothelial cells may possess an intrinsic capability of transitioning
to mesenchymal progenitors [30] opens tremendous possibilities
for the role of endothelial cells in this model.
In our model, the MSCs have two major roles: as pericytes
stabilizing vascular networks and as osteogenic progenitors
forming mineralized bone matrix. Several published studies show
that bone marrow-derived MSCs adopt pericyte-like locations
during in vitro co-culture with mature endothelial cells [15,31,32]
or when co-delivered in vivo with mature endothelial cells
[24,33,34]. Our study supports these previous observations as
the capillary-like structures formed by HUVECs were only stable
in the presence of hMSCs (Fig. S1).
The ability of MSCs to respond with spatial and temporal
specificity to differentiation cues was key in gel studies where all
cells were seeded at the beginning of culture and no cells could be
introduced at later stages of culture (supplemental data). From
these preliminary studies, several key outcomes were identified
that determined the selection of experimental groups for the
subsequent scaffold study: (i) a sequential-induction approach
enabled vascular-osteogenic outcomes within the same culture
space, with the need for endothelial growth factors to be provided
prior to osteogenic induction, and (ii) the role of BMPs as a
vascular promoter was confirmed [35] even during in vitro culture.
Mineralization of the tissue matrix was evident in the groups
containing vascular networks, although to limited extent as cells
were exposed to osteo-inductive medium for only two weeks.
Thus, a longer osteo-induction period was adopted during scaffold
studies.
Trabecular bone scaffolds also provided great versatility of the in
vitro co-culture system and enabled the evaluation of concurrent
supplementation of growth factors and fresh MSCs responding to
these growth factors. We also investigated the hypothesis of MSCs
losing their ability to respond to osteogenic factors during the two-
week exposure to vascular supplements, by comparing Group 4
(EGM|cocktail+MSC, in which osteo-induced MSCs were
added along with cocktail medium) with the Group 3 (EGM|cock-
tail, in which the same MSCs present at the beginning of culture
were exposed to cocktail medium). Data suggests that fresh MSCs
enhance bone formation, as verified by increased bone volume
fraction (Fig. 4), osteoid deposition (Fig. 5), and spatial proximity of
bone proteins to vascular networks (Fig. 3). However the addition of
additional MSCs is not critical, as bone formation also occurred in
Group 3 (EGM|cocktail). This suggests that MSCs may act
initially as pericytes [15,31,32], but maintain the ability to undergo
osteogenesis, which is arguably consistent with the prior evidence
that osteoblasts take up pericytic locations in vivo [3].
Figure 4. Ratio of bone material volume over tissue volume
(BV/TV) of constructs after in vitro culture. n= 3; * indicate p,0.05
and ** indicate p,0.001 in comparison to unseeded group. # indicate
p,0.05 among both groups.
doi:10.1371/journal.pone.0028352.g004
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By adding HUVECs at the latter stages of culture, it was
possible to evaluate osteogenesis that has been induced in the
scaffolds prior to providing vascular cells and growth factors, an
approach similar to that taken by Tsigkou et al [15]. This
approach to improve vascularized bone tissue development
(OM|cocktail group) was moderately successful: we observed
reasonable osteogenic development as evidenced by deposition of
bone protein, osteoid formation and the BV/TV ratio. However,
two-week exposure to vascular growth factors was not sufficient to
develop robust vascular structures, as evidenced by the sizes of
vessel lumens that were smaller than those observed in Groups 3
and 4. In these two groups, not only lumen were evident after in
vitro cultivation, they also anastomosed well during in vivo
implantation, which is consistent with the earlier reports that
well-developed vascular networks are necessary for functional
anastomosis [36,37,38,39], although recent studies suggest that is
also possible to obtain functional network formation without
extensive in vitro cultivation [8,15]. These studies open several
under-explored areas of investigation. For example, the DNA
content was considerably higher in the OM group relative to the
EGM group, suggesting that HUVECs may have survived better
as a result of BMP2 supplementation in osteogenic media (Fig. 4).
In future studies, it might be relevant to distinguish whether
HUVECs and MSCs are equally stimulated in this group and to
Figure 5. Composition of engineered grafts. Top row: Gross images of constructs post-harvest showing the translucent capsule and the in-
growth of blood vessels. Constructs are perfused to different extents in different experimental groups. The large blood vessels also seem to
anastomose to engineered microvasculature resulting in blood flow through capillary-like networks. This is particularly evident in EGM|cocktail and
EGM|cocktail+MSC groups. Scale bar = 500 mm. Second row: Constructs were stained with anti-human CD31. Capsular region filled with mouse
cells are shown with asterisks (*). In EGM|cocktail and EGM|cocktail+MSC groups, lumen (stained with anti-human CD31) are larger and well-
developed (black arrows) with red blood cells inside (stained with hematoxylin). In OM|cocktail group, there is little evidence of human-derived
vascular tissue. Large vessel-like structures in the capsular region are not stained with anti-human CD31 mAb and are probably of mouse origin
(yellow arrow heads). Scale bar = 50 mm. Rows 3 and 4: In vivo bone development. Goldner’s Masson trichrome staining of non-decalcified
constructs indicate distinct levels of osteoid formation among groups (red stains indicated by black arrow heads). Third row: scale bar = 20 mm,
Bottom row: scale bar = 500 mm.
doi:10.1371/journal.pone.0028352.g005
In Vitro Model of Vascularized Bone
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28352
decipher the role of cell proliferation in tissue development. Also,
despite promising results, our studies suggest that alternative
cocktails (e.g. EGM|OM or increased vascular growth factor
concentration in OM|cocktail group) could be tested to
synergistically improve mineralization with vascular network
formation. Likewise, further studies are needed to optimize the
temporal stages of culture, as the two-week period of vascular
induction was selected based on the robust network structures
observed for fibrin gel studies.
Overall, by providing temporal variation of the culture
environment, we were able to demonstrate the ability to derive
vascular networks and induce bona fide osteogenic differentiation
within single tissue grafts during in vitro cultivation. Notably,
functional vascular networks and viable osteoid formation were
detected post-implantation. The most successful approach in-
volved induction of vasculogenesis prior to osteogenesis, with the
addition of osteo-induced MSC further improving tissue outcomes.
Finally, while the focus of our study was to evaluate ‘functional’
outcomes such as vessel formation and matrix mineralization,
significantly more work is needed to elucidate the underlying
mechanisms that regulate heterotypic interactions and understand
the interactive roles of multiple growth factors.
In summary, it has long been accepted that vascularization is
essential for the advancement of tissue-engineered bone grafts to
clinical application [40]. Due to the close interaction between
MSCs and HUVECs in co-culture systems, it may be possible to
utilize the proposed tissue engineering model as a controllable
experimental tool to elucidate other molecular mechanisms
regulating the heterotypic cell-cell interactions. Such studies could
have relevance for gaining further insights into developmental
processes [41] and cellular interactions under conditions of
disease.
Supporting Information
Figure S1 Gel cultivation. A: HUVECs only at 3 weeks in
EGM-2. Co-culture of HUVECs with MSCs (1:1) enables
formation of stable micro-vasculature networks at 3 weeks in
EGM-2 (B) that last up to 12 weeks (C) during in vitro culture. D:
von Willebrand Factor (vWF) staining of lumen.
(JPG)
Figure S2 Gel screening studies. HUVECs (pre-stained with
Di-I) and MSCs were encapsulated in fibrin hydrogels (1:1 ratio)
and cultured in small wells for 4 weeks to determine cellular
responses to different medium conditions. Confocal images were
used to evaluate vascular network formation and provide a read-
out on HUVEC viability (cellular debris). Scale bar = 50 mm.
Bottom row: von Kossa staining of mineral deposition within the
gel regions. Mineral is shown as black/dark brown stains within
the gels.
(JPG)
Figure S3 H&E staining of constructs at day 1. Cells are
uniformly distributed throughout the scaffold upon seeding. Cells
are located predominantly on the wall surfaces of scaffolds but
grow into pore spaces subsequently.
(JPG)
Figure S4 EGM|cocktail+MSC group stained with anti-
human CD31 mAb. Human origin lumen, with red blood cells
inside (stained with hematoxylin) are pointed with yellow arrows.
(JPG)
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